Back to News
Market Impact: 0.2
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & BiotechInvestor Sentiment & Positioning
Arcutis Biotherapeutics (ARQT) recorded an outsized price move on above-average trading volume in the prior session. However, recent earnings-estimate revision trends are unfavorable and may limit the stock's ability to sustain further near-term gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
ARQT-0.30
More News
- Oil Traders Stymied by Iran War Stalemate: Evening Briefing Americas
- Asian stocks rise as oil retreat eases inflation fears, BOJ in focus
- A breakout in the 10-year Treasury yield could hold back stocks if it reaches this level
- Kevin Warsh, an angry Trump and Jerome Powell Déjà vu: how history is repeating itself
- Fed rate decision and Warsh comments roiled markets. Where to find opportunities
- Biweekly Investment Insights: Markets swirl